Hep C Can Be Eliminated by 2030, Worldwide

News
Slideshow

A new study models the impact of 4 key public health interventions on global HCV burden to see if WHO elimination targets are realistic.

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
Oral Antiviral Candidate Shows Promise for RSV Treatment: Daily Dose / image credit: ©New Africa/AdobeStock

Oral Antiviral Candidate Shows Promise for RSV Treatment: Daily Dose

Sydney Jennings
February 14th 2025
Article

Your daily dose of the clinical news you may have missed.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Investigational RSV Antiviral Treatment Reduces Viral Load in Phase 2 Human Challenge Trial

Investigational RSV Antiviral Treatment Reduces Viral Load in Phase 2 Human Challenge Trial

Sydney Jennings
January 30th 2025
Article

The study of S-337395 showed an 88.9% reduction in RSV viral load and symptom improvement in the highest dose group, with no severe adverse events reported.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment / Image credit: ©Mauro Rodrigues/AdobeStock

Sen-Jam Pharmaceutical Reports Preliminary Phase 2 Results for SJP-002C in COVID-19 Treatment

Sydney Jennings
January 20th 2025
Article

The novel therapeutic demonstrated a strong safety profile and showed efficacy in reducing symptoms during the early stages of treatment.

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning / Image credit: ©MargJohnsonVA/AdobeStock

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning

Sydney Jennings
January 8th 2025
Article

The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.

© 2025 MJH Life Sciences

All rights reserved.